Vasculitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Study of CCX168 in Japanese and Caucasian Healthy Adult Males
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: CCX168;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Intervention:   Drug: CCX168 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

A Study of CCX168 in Japanese and Caucasian Healthy Adult Males
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: CCX168;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Intervention:   Drug: CCX168 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials

A Study of CCX168 in Japanese and Caucasian Healthy Adult Males
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: CCX168;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168
Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Intervention:   Drug: CCX168 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants
Conditions:   Vasculitis;   Systemic Lupus Erythematosus (SLE) Interventions:   Drug: CCX168;   Drug: Placebo Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials